PLC-derived organoids with the HCC feature demonstrated a high sensitivity to anticancer drugs like Gemcitabine, AZD8931, SCH772984, Taselisib, and Dasatanib. This evidence concerns the gene HSPG2 and hepatocellular carcinoma.